Articles From: UPDATE: Marin Cilic of Croatia wins the 2014 U.S. Open for his first-ever Grand Slam title to UPDATE: Google, GoPro are stocks to watch Wednesday


2014/9/9
By Steven Kutz, MarketWatch Croatian Marin Cilic won his first-ever Grand Slam title on Monday by defeating Japan's Kei Nishikori 6-3, 6-3, 6-3.
Sign-up for UPDATE: Marin Cilic of Croatia wins the 2014 U.S. Open for his first-ever Grand Slam title investment picks
2014/9/8
By Steven Kutz, MarketWatch Croatian Marin Cilic won his first-ever Grand Slam title on Monday by defeating Japan's Kei Nishikori 6-3, 6-3, 6-3.
Sign-up for UPDATE: Marin Cilic of Croatia wins the 2014 U.S. Open for his first-ever Grand Slam title investment picks
2014/9/8
By Steven Kutz, MarketWatch Croatian Marin Cilic won his first-ever Grand Slam title on Monday by defeating Japan's Kei Nishikori 6-3, 6-3, 6-3.
Sign-up for UPDATE: Marin Cilic is your 2014 U.S. Open winner investment picks
2014/9/8
By Steven Kutz, MarketWatch Croatian Marin Cilic won his first-ever Grand Slam title on Monday by defeating Japan's Kei Nishikori 6-3, 6-3, 6-3.
Sign-up for Marin Cilic is your 2014 U.S. Open winner investment picks
2014/9/8
By Steven Kutz, MarketWatch For the first time in nearly a decade, a Grand Slam men's final will be played that won't include Roger Federer, Rafael Nadal or Novak Djokovic.
Sign-up for UPDATE: U.S. Open final will be without Federer, Djokovic -- and Nike investment picks
2014/9/8
By Steven Kutz, MarketWatch For the first time in nearly a decade, a Grand Slam men's final will be played that won't include Roger Federer, Rafael Nadal or Novak Djokovic.
Sign-up for UPDATE: U.S. Open final will be without Federer, Djokovic -- and Nike, Adidas investment picks
2014/7/22
By Steven Norton The international conflict over Russia's involvement in Ukraine and its possible link to the downing of Malaysian Airlines Flight 17 has spilled into the western technology sector.
Sign-up for Ukraine-Russia fallout could hurt U.S. tech sector investment picks
Merkerson Visits Dallas, Texas on August 14 With America's Diabetes Challenge: Get to Your Goals Program WHITEHOUSE STATION, N.J. , Aug.
Sign-up for Award-Winning Actress S. Epatha Merkerson and Merck Challenge African Americans with Type 2 Diabetes to Get to Their Goals investment picks
Merkerson Visits Washington, D.C. on June 26 With America's Diabetes Challenge: Get to Your Goals Program WHITEHOUSE STATION, N.J. , June 26, 2014 /PRNewswire/ -- Merck (NYSE: MRK) , known as MSD outside the United States and Canada , and actress S.
Sign-up for Award-Winning Actress S. Epatha Merkerson and Merck Challenge African Americans with Type 2 Diabetes to Get to Their Goals investment picks
2014/7/14
CHARLOTTE, N.C. , July 14, 2014 /PRNewswire/ -- FARNBOROUGH AIR SHOW --
Sign-up for UTC Aerospace Systems offers its Prime Solutions® suite of nacelle maintenance services to operators of the Airbus A350 XWB investment picks
Active Defense 2.0 Analyzes and Detects Malicious Code in Memory and Helps to Pinpoint Compromised Systems in Order to Eliminate Threats FAIRFAX, Va.
Sign-up for ManTech Cyber Solutions International, Inc. Announces Advanced Visibility and Rapid Discovery of Endpoints with Active Defense™ 2.0 investment picks
iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today announced the signing of a definitive agreement to acquire DermEbx™, a leading electronic brachytherapy services and technology provider, and Radion, Inc., a cloud-based oncology collaboration software solution.
Sign-up for iCAD Acquires DermEbx and Radion to Provide Powerful Comprehensive Skin Cancer Treatment Solution to the Dermatology Market investment picks
Exchange Income Announces Expansion of Executive Management Team Canada NewsWire - Changes driven by growth and diversification opportunities - WINNIPEG , July 8, 2014 /CNW/ - Exchange Income Corporation (TSX: EIF) (the "Corporation"), a diversified, acquisition-oriented company focused on opportunities in three sectors (aviation services and equipment, metal manufacturing, and infrastructure services) announced today a series of changes to its executive management team that are designed to position the Company for continued growth and diversification.
Sign-up for Exchange Income Announces Expansion of Executive Management Team investment picks
MINNEAPOLIS, July 28, 2014 (GLOBE NEWSWIRE) -- Manny Villafaña, Chairman and CEO of Kips Bay Medical Inc. (Nasdaq:KIPS) , announced that on July 17, 2014, Lenox Hill Hospital in New York City performed its first implant of an eSVS® Mesh.
Sign-up for Kips Bay Medical Announces the First eSVS Mesh Implant by Lenox Hill Hospital of New York investment picks
MINNEAPOLIS, Aug.
Sign-up for Kips Bay Medical Receives Updated CE Mark Approval investment picks
One of the Nation's Largest Safety Net Health Systems will Use the Market Leading Business Analytics Solutions to Measure, Predict, and Improve its Financial and Operational Performance ATLANTA , July 28, 2014 /PRNewswire/ --
Sign-up for Eskenazi Health Signs Agreement For Business Analytics And Patient Financial Solutions From Streamline Health® investment picks
2014/8/4
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1135166&ProfileId=051205&sourceType=1 MADISON HEIGHTS, MI --
Sign-up for Creative Edge Nutrition Inc. Announces the Addition of Dr. Jonathan Lakey as the Chief Science Officer of Stem Cell & Tissue Research investment picks
NanoString Technologies, Inc., (NASDAQ:NSTG) a provider of life science tools for translational research and molecular diagnostic products, today announced the introduction of a new highly multiplexed gene expression panel for the nCounter ® Analysis System, the PanCancer Immune Profiling Panel.
Sign-up for NanoString Introduces Novel Gene Expression Panel for Immuno-Oncology Research investment picks
2014/8/19
MARTINSRIED, Germany and MUNICH, Germany, Aug.
Sign-up for MorphoSys and Emergent BioSolutions Sign License Agreement to Co-Develop and Commercialize Prostate Cancer Drug Candidate ES414 investment picks
Emergent BioSolutions Inc. (NYSE: EBS) and MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX, OTC: MPSYY) today announced an agreement for the joint development and commercialization of Emergent’s preclinical bi-specific antibody, ES414, targeting prostate cancer.
Sign-up for Emergent BioSolutions and MorphoSys Sign License Agreement to Co-Develop and Commercialize Prostate Cancer Drug Candidate ES414 investment picks
SiriusXM Canada auto dealer programs receive Reynolds certification Canada NewsWire TORONTO , Sept.
Sign-up for SiriusXM Canada auto dealer programs receive Reynolds certification investment picks
2014/8/14
By Sue Chang, MarketWatch SAN FRANCISCO (MarketWatch)--J.C. Penney Co.
Sign-up for J.C. Penney jumps on results, Monster soars after hours investment picks
2014/9/10
By Sue Chang, MarketWatch SAN FRANCISCO (MarketWatch) -- These are the companies whose shares are expected to see active trade in Wednesday's session: Apple Inc.(AAPL): The iPhone maker unveiled the highly anticipated iPhone 6, iPhone 6 Plus and Apple Watch, plus a mobile payments system.
Sign-up for UPDATE: Apple, Krispy Kreme, Men's Wearhouse in focus investment picks
2014/6/17
By Sue Chang, MarketWatch SAN FRANCISCO (MarketWatch) -- Among the companies whose shares are expected to see active trade in Tuesday's session are Adobe Systems Inc., La-Z-Boy Inc., and Kindred Healthcare Inc. Adobe (ADBE) is projected to report fiscal second-quarter earnings of 30 cents a share, according to a consensus survey by FactSet.
Sign-up for UPDATE: Adobe, La-Z-Boy, Kindred are stocks to watch investment picks
2014/6/30
By Sue Chang, MarketWatch SAN FRANCISCO (MarketWatch)--Among the companies whose shares are expected to see active trade in Monday's session are MannKind Corp., Apple Inc., and Facebook Inc. MannKind Corp.(MNKD):The Food and Drug Administration has approved MannKind's inhaled insulin Afrezza, but there is widespread skepticism over the new product.
Sign-up for UPDATE: MannKind, Apple, Facebook are stocks to watch investment picks
2014/6/29
By Sue Chang, MarketWatch SAN FRANCISCO (MarketWatch)--Among the companies whose shares are expected to see active trade in Monday's session are MannKind Corp., Apple Inc., and Facebook Inc. MannKind Corp.(MNKD):The Food and Drug Administration has approved MannKind's inhaled insulin Afrezza, but there is widespread skepticism over the new product.
Sign-up for MannKind, Apple, Facebook are stocks to watch investment picks
2014/6/27
By Sue Chang, MarketWatch SAN FRANCISCO (MarketWatch) -- Among the companies whose shares are expected to see active trade in Friday's session are DuPont, Nike Inc., and KB Home.
Sign-up for UPDATE: DuPont, Nike, KB Home are stocks to watch investment picks
2014/6/25
By Sue Chang, MarketWatch SAN FRANCISCO (MarketWatch) -- Among the companies whose shares are expected to see active trade in Wednesday's session are Google Inc., and Barnes and Noble Inc. Google(GOOG) (GOOGL) will host its annual developers conference in San Francisco, where it is expected to show off new enhancements for its operating system.
Sign-up for UPDATE: Google, Barnes & Noble are stocks to watch Wednesday investment picks
2014/6/25
By Sue Chang, MarketWatch SAN FRANCISCO (MarketWatch) -- Among the companies whose shares are expected to see active trade in Wednesday's session are Google Inc., GoPro, and Nike Inc. Google(GOOGL) will host its annual developers conference in San Francisco where it is expected to show off new enhancements for its operating system.
Sign-up for UPDATE: Google, GoPro are stocks to watch Wednesday investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: UPDATE: Marin Cilic of Croatia wins the 2014 U.S. Open for his first-ever Grand Slam title to UPDATE: Google, GoPro are stocks to watch Wednesday
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices